Compare Xertra (STRAX) vs Venom (VENOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Xertra vs Venom — how do they compare? Xertra trades at Rp145.89 (market cap Rp318,44M, Rp6,91M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Xertra and Venom are close in size by market cap, and Venom's supply is capped (988,9M / 8B VENOM (13%)) while Xertra's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Xertra for 39 Days and Venom for 24 Days on average.
| STRAX | VENOM | |
|---|---|---|
Market Cap | Rp318,44M | Rp340,86M |
Volume (24h) | Rp6,91M | Rp2,89M |
Circulating Supply | 2,2B STRAX | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 39 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
STRAX is currently trading at Rp147.7, exhibiting a bearish technical trend with mixed signals; moving averages indicate selling pressure while oscillators show some bullish momentum. The asset faces resistance near Rp158 and finds support at Rp139. No recent protocol updates or significant ecosystem developments were noted. Trading volume remains modest with a market cap of Rp322.67M.
Overall outlook is cautious due to bearish technicals and lack of fundamental catalysts. Key opportunities lie in oversold oscillator signals suggesting potential rebounds, but major risks include low liquidity and high volatility. Investors should monitor for any network updates or exchange listings that could impact price action.
VENOM displays limited market activity with a modest market cap of Rp340.86M and only 13% of its maximum 8M token supply in circulation. The asset shows minimal trading volume and network activity, with an average hold time of 24 days indicating cautious investor behavior. No recent protocol updates or significant ecosystem developments have been observed, suggesting stagnant project growth.
Overall outlook remains cautious due to limited liquidity and adoption. Key opportunity lies in potential future protocol development, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor for any signs of renewed developer activity or exchange listings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Xertra
Stratis is a blockchain-as-a-service platform that offers several products and services for enterprises, including launching private sidechains, running full nodes, developing and deploying smart contracts, an initial coin offering platform, and a proof-of-identity application. The company also provides cryptocurrency wallets and blockchain consulting services.
Read more on STRAX →About Venom
Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →
